The orthobiological product market includes medicines, devices and procedures for bone and tissue replacements and is anticipated to witness lucrative growth during the forecast period. Rising prevalence of injuries and medical disorders such as osteoporosis, arthritis, and rheumatoid arthritis are the key drivers for market growth. Increasing outdoor activities and changing lifestyle of people, coupled with the spirit of adventure, is a propeller for the market growth. Other drivers include rising disposal incomes, increasing spending by people on aesthetic appeal, augmenting awareness level of the benefits of orthobiologic procedures, and enhancing investments by market players into the market.
Viscosupplementation held the largest market share for the product segment of the market owning to higher performance and benefits perceived to the patients. The benefits include higher and long lasting pain relief post operative procedure. The dominance is anticipated to be maintained during the forecast period. Stem cell therapy is expected to witness lucrative and fastest growth during the forecast period, due to cost efficiency and enhancing therapeutic effects. On the basis of application, spinal fusion held the largest share of the market. North America records the highest number of spinal fusion surgeries performed with about 465,000 procedures during 2011. Reconstructive surgeries segment is expected to be the fastest growing segment during the forecast period, owning to rising cosmetic surgeries and increasing incidences of injuries and accidents.
View More Details About Orthobiological Products Market:
North America held the largest share of the orthobiologic product market and the dominance is expected to continue during the forecast period. The drivers of this growth are growing sophisticated infrastructure, increasing sale of medical devices, rising occurrence of incidents and medical disorders requiring surgeries and procedures. Government assistance in R&D and increasing awareness level are the other impact rendering drivers of the region. Europe is anticipated to follow North America with Germany, leading the market in the region. The factors influencing the growth include, rising population base of geriatrics, increasing manufacturing and sales initiatives by the companies, rising disposal income availability, and growing awareness level towards non-invasive surgeries and cosmetology. Asia Pacific is expected to be the fastest growing region during the forecast period owning to supportive government policies and economic planning, increasing availability of advancement products in the region, expansion, and modernization of existing companies, and enhancing R&D.
Major market players include Pioneer Surgical Technology, Kinetic Concepts Inc., Tissue Banks International, Spinal Restoration, Medtronic Inc., Smith & Nephew plc, Bone Solutions Inc, Allograft Tissue Systems, Interventional Spine Inc., DePuy Synthes Inc., Berkeley Advanced Biomaterials Inc., Baxter International Inc., Tissue Genesis Inc, Bone Biologics Inc., Sanofi, Integra Life Sciences Corp., Stryker Corp., Osiris Therapeutics Inc., Globus Medical, and others. Technological advancements and combating the rising need of reconstructive surgeries are expected to enhance the growth of the market and provide new avenues for R&D investment and profit earning.
View All Market Research Reports Of This Category:
About Grand View Research:
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States